V CompBrief BY VELARION

Executive Vice President, Diabetes Care · ABBOTT LABORATORIES (ABT)

Christopher Scoggins

FY2025 is the first fiscal year CompBrief holds for Christopher Scoggins as a named executive officer of ABBOTT LABORATORIES; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Velarion Intel: free for 3 days, no card →

Total disclosed compensation, FY2025

$6,601,667

5th of 6 named executive officers at Abbott Laboratories by FY2025 total.

6 named officers on file for ABBOTT LABORATORIES, FY2025

See an example →

What this number hides

The filing gives the total. ABBOTT LABORATORIES’s full Executive Compensation Report gives every award, the disclosed peer set and what the total leaves out — the pair adds the board’s.

Velarion Intel · free for 3 days · no card

See how ABBOTT LABORATORIES’s whole pay program stands against its peers

  • ABBOTT LABORATORIES’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ABT→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed March 13, 2026 (DEF 14A).

Free

Get Christopher Scoggins’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Christopher Scoggins and every company like it: Velarion Intel, free for 3 days, no card →

Christopher Scoggins compensation by year

ABBOTT LABORATORIES Summary Compensation Table · the one fiscal year held
In US dollars, as ABBOTT LABORATORIES reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2025
Salary$859,502
Bonus$0
Stock awards$1,662,503
Option awards$1,662,743
Non-equity incentive$1,095,300
Pension and deferred compensation$1,213,176
All other$108,443
Total$6,601,667

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ABBOTT LABORATORIES DEF 14A filed March 13, 2026, accession 0001308179-26-000064, and prior-year filings. Open the filing on EDGAR.

How this page was built: the ABBOTT LABORATORIES filed document, accession 0001308179-26-000064. Every figure is read from that document and cited to the page and table it appears in. Filed March 13, 2026.

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
RSU12,278$1,538,310—
RSU5,627$705,007—
RSU3,168$396,919—
Option21,148—$116.98
Option43,388—$79.98
Option51,557—$75.90
Option68,578—$87.72
Option12,495—$106.24
Option63,991—$124.04
Option48,852—$117.58
Option45,730—$135.42

Per the Outstanding Equity Awards at Fiscal Year-End table in ABBOTT LABORATORIES's FY2025 proxy; value at the fiscal year-end close, as the company printed it.

ABBOTT LABORATORIES’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Robert FordChairman of the Board and Chief Executive Officer$24,198,660
Philip BoudreauExecutive Vice President, Finance and Chief Financial Officer$9,090,636
Lisa EarnhardtExecutive Vice President and Group President, Medical Devices$8,069,724
Hubert AllenFormer Executive Vice President, General Counsel and Secretary$6,995,583
Christopher Scoggins · this pageExecutive Vice President, Diabetes Care$6,601,667
Daniel SalvadoriExecutive Vice President and Group President, Established Pharmaceuticals and Nutritional Products$6,534,285

Christopher Scoggins's compensation dossier, ABBOTT LABORATORIES

You have read Christopher Scoggins's totals and holdings. The dossier adds each equity grant ABBOTT LABORATORIES disclosed for Christopher Scoggins and ABBOTT LABORATORIES's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.

See an example →

The full ABBOTT LABORATORIES compensation record

free company brief
ABBOTT LABORATORIES (ABT) — free Compensation Briefevery named executive and director, board pay, say-on-pay, the peer group

This page is one person within ABBOTT LABORATORIES's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the ABBOTT LABORATORIES proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order ABBOTT LABORATORIES's full Executive Compensation Report with peer benchmarking.

Open the Daily Digestfree · newest disclosuresFull report & benchmarkingExecutive Compensation Report · $500
How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are ABBOTT LABORATORIES's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Order ABT

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Christopher Scoggins's compensation dossier